Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Contrast Agents for Magnetic Resonance Imaging (MRI) Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Supply by Company

    • 2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Company
    • 2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Company
    • 2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Company
    • 2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status by Category

    • 3.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Category Introduction
      • 3.1.1 Barium-based Contrast Media
      • 3.1.2 Iodinated Contrast Media
      • 3.1.3 Gadolinium-based Contrast Media
      • 3.1.4 Microbubble Contrast Media
    • 3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Category
      • 3.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Category (2016-2021)
      • 3.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Category (2016-2021)
      • 3.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status by End User/Segment

    • 4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by End User/Segment
      • 4.1.1 Radiology
      • 4.1.2 Interventional Radiology
      • 4.1.3 Interventional Cardiology
    • 4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by End User/Segment
      • 4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status by Region

    • 5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Region
      • 5.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Region
      • 5.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Region
    • 5.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status
    • 5.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status
    • 5.4 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status
    • 5.5 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status
    • 5.6 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status

    6 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status

    • 6.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Country
      • 6.1.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status

    • 7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Country
      • 7.1.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status

    • 8.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Country
      • 8.1.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status

    • 9.1 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Country
      • 9.1.1 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Status

    • 10.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Country
      • 10.1.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Cost Analysis
    • 11.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channel and Distributors Analysis
      • 11.5.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channel
      • 11.5.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
    • 11.6 Contrast Agents for Magnetic Resonance Imaging (MRI) Downstream Major Buyers

    12 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Forecast by Category and by End User/Segment

    • 12.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Category
      • 12.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Forecast by Category
      • 12.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Forecast by Category
      • 12.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by Category
    • 12.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by End User/Segment
      • 12.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Forecast by End User/Segment
      • 12.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by End User/Segment

    13 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Forecast by Region/Country

    • 13.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Unijules Life Sciences (India)
      • 14.1.1 Company Information
      • 14.1.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.1.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Taejoon Pharm (South Korea)
      • 14.2.1 Company Information
      • 14.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.2.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Spago Nanomedicine (Sweden)
      • 14.3.1 Company Information
      • 14.3.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.3.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Magnus Health (India)
      • 14.4.1 Company Information
      • 14.4.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.4.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Lantheus (US)
      • 14.5.1 Company Information
      • 14.5.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Jodas (India)
      • 14.6.1 Company Information
      • 14.6.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.6.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 J.B. Chemicals and Pharmaceuticals (India)
      • 14.7.1 Company Information
      • 14.7.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.7.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Guerbet (France)
      • 14.8.1 Company Information
      • 14.8.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.8.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 GE Healthcare (US)
      • 14.9.1 Company Information
      • 14.9.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.9.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Daiichi Sankyo (Japan)
      • 14.10.1 Company Information
      • 14.10.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
      • 14.10.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Bracco Imaging (Italy)
    • 14.12 Bayer HealthCare (Germany)

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Contrast Agents for Magnetic Resonance Imaging (MRI) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Barium-based Contrast Media
      Iodinated Contrast Media
      Gadolinium-based Contrast Media
      Microbubble Contrast Media

      Segmented by End User/Segment
      Radiology
      Interventional Radiology
      Interventional Cardiology

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Unijules Life Sciences (India)
      Taejoon Pharm (South Korea)
      Spago Nanomedicine (Sweden)
      Magnus Health (India)
      Lantheus (US)
      Jodas (India)
      J.B. Chemicals and Pharmaceuticals (India)
      Guerbet (France)
      GE Healthcare (US)
      Daiichi Sankyo (Japan)
      Bracco Imaging (Italy)
      Bayer HealthCare (Germany)
      Buy now